{
    "2020-12-16": [
        [
            {
                "time": "",
                "original_text": "周期、科技、消费……热门板块明年怎么买？银河证券分析师：这些机会值得关注！",
                "features": {
                    "keywords": [
                        "周期",
                        "科技",
                        "消费",
                        "热门板块",
                        "银河证券"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "周期",
                        "科技",
                        "消费"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "2021年医药生物行业策略报告：聚焦黄金赛道，寻找疫后高光",
                "features": {
                    "keywords": [
                        "2021年",
                        "医药生物",
                        "行业策略",
                        "黄金赛道",
                        "疫后高光"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "沃森生物“贱卖”资产闹剧：疫苗股高处不胜寒 资产异常",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "贱卖",
                        "资产",
                        "疫苗股",
                        "高处不胜寒",
                        "资产异常"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}